Vtv Therapeutics Inc (VTVT) - News Archive

: vTv Therapeutics, a clinical-stage pharmaceutical company, has released its financial results for the fourth quarter and full year of 2024. The announcement highlights strategic corporate advancements alongside signif...

vTv Therapeutics Inc. Faces Setback in Promising Diabetes Research HIGH POINT, N.C., July 26, 2024 vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company renowned for its innovative clinical portfo...

vTv Therapeutics Inc., a renowned clinical stage biopharmaceutical company with a focus on the development of innovative treatments, has recently submitted the study protocol for its first Phase 3 trial to the U.S. Food...

vTv Therapeutics, a renowned pharmaceutical company focused on developing innovative treatments for chronic diseases, has recently announced a major milestone in its journey to combat type 1 diabetes (T1D). The company...